tiprankstipranks
Trending News
More News >
Viridian Therapeutics (VRDN)
NASDAQ:VRDN

Compare Viridian Therapeutics (VRDN) vs. Competitors

Compare
1,458 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Viridian Therapeutics
$32.93
$3.16B
-9.36
79.19%
13 Buy
0 Hold
0 Sell
Strong Buy
Dianthus Therapeutics
$52.33
$2.19B
-14.65
141.25%
8 Buy
0 Hold
0 Sell
Strong Buy
Pharvaris
$27.59
$1.77B
-8.57
47.23%
8 Buy
1 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$28.02
$2.97B
-17.77
-0.99%
8 Buy
1 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$14.64
$880.56M
-8.74
-66.81%
14 Buy
2 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$12.74
$1.85B
-1.68
-67.61%
9 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRDN
Viridian Therapeutics
33.06
14.15
74.83%
DNTH
Dianthus Therapeutics
51.17
30.07
142.51%
PHVS
Pharvaris
27.59
9.57
53.11%
EWTX
Edgewise Therapeutics
28.02
0.17
0.61%
JANX
Janux Therapeutics Inc
14.64
-28.90
-66.38%
BHVN
Biohaven Ltd.
12.74
-27.19
-68.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts